Article
Use of fertility treatments in BRCA1/2 mutation carriers and risk for ovarian and breast cancer: a systematic review.
Archives of gynecology and obstetrics - 1 Sept 2020
Huber D, Seitz S, Kast K, Emons G, Ortmann O
Abstract excerpt
PURPOSE: Mutations in the genes BRCA1 and BRCA2 represent a significant risk factor for ovarian and breast cancer. With increasing number and success rates, fertility protection and treatment are gaining importance also for BRCA1/2 mutation carriers. However, the effect on primary cancer risk and risk for recurrence remains unclear. This review analyses the published data on fertility treatment and risk of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
